The AACR Health Policy Subcommittee develops and promotes policies and member education initiatives that will foster the closer integration of clinical practice and cancer research.
The Health Policy Subcommittee (HPS) of the Science Policy and Government Affairs Committee was created to address policy issues and member education initiatives that will foster the closer integration of, and clarify the evolving relationship between, cancer research and clinical practice.
Focus areas of the subcommittee include comparative effectiveness research (CER), health information technology (HIT), patient-reported outcomes (PROs) and patient participation in clinical research.
Amy P. Abernethy, M.D., Chairperson
Duke University School of Medicine
Karen H. Antman, M.D.
Boston University School of Medicine
William S. Dalton, M.D., Ph.D.
M2Gen, Personalized Medicine Institute at Moffitt Cancer Center
Mark A. Israel, M.D.
Dartmouth Norris Cotton Cancer Center
Richard Kouri, Ph.D.
North Carolina State University
Thomas J. Lynch, Jr., M.D.
Yale Cancer Center
New Haven, CT
Peter J. Neumann, Sc.D.
Tufts Medical Center
Steven R. Patierno, Ph.D.
Duke University Medical Center
Scott Ramsey, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
Mark E. Robson, M.D.
Memorial Sloan-Kettering Cancer Center
New York, NY
Deborah Schrag, M.D., M.P.H.
Dana-Farber Cancer Institute, Harvard Medical School
Ellen V. Sigal Ph.D.
Friends of Cancer Research
Sean Tunis, M.D., M.Sc.
Center for Medical Technology Policy (CMTP)
AACR Staff Contact:
Jennifer Hobin, Ph.D.,
Director of Science Policy
AACR Office of Science Policy and Government Affairs
Email or call (202) 898-6499